MedTrace Logo

Leuprolide in Treating Adults With Hypogonadotropism

NCT00004438 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2015-03-25

No results posted yet for this study

Summary

RATIONALE: Hypogonadotropism is an abnormal condition caused by decreased production of gonadotropins, a group of hormones that stimulate the parts of the reproductive system that produce and release eggs from the ovaries or sperm from the testicles. Leuprolide may stimulate the production of gonadotropins and be effective in increasing testosterone in men and inducing ovulation in women.

PURPOSE: Clinical trial to study the effectiveness of leuprolide in treating adults who have hypogonadotropism.

Conditions

  • Hypogonadism

Interventions

DRUG

leuprolide

Sponsors & Collaborators

  • University of Chicago

    lead OTHER

Principal Investigators

  • Robert L. Rosenfield · University of Chicago

Study Design

Purpose
TREATMENT

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1997-09-30
Completion
2002-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00004438 on ClinicalTrials.gov